Back To Search Results

Anaerobic Infections

Editor: Ellis H. Tobin Updated: 5/13/2026 5:57:19 AM

Introduction

Anaerobic bacteria are microorganisms that replicate in the absence of oxygen. Oxygen is toxic to many anaerobic bacteria, with some exceptions, primarily because many anaerobes lack protective enzymes, eg, catalase, superoxide dismutase, and peroxidase that neutralize molecular oxygen and reactive oxygen species (ROS).[1]

Bacteria can be classified into the following types based on their oxygen requirement:

  • Obligate aerobes: These bacteria require oxygen for metabolism and growth. Obligate aerobes do not have any other source of energy, eg, fermentation. Examples include Pseudomonas aeruginosa and Mycobacterium tuberculosis.
  • Facultative anaerobes: These bacteria can grow in the presence or absence of oxygen. Oxygen is utilized when present, but when absent, the organisms will switch to fermentation or anaerobic respiration. Examples include Escherichia coli and Staphylococcus aureus.
  • Obligate anaerobes: This type of bacteria cannot tolerate oxygen, which may cause death or severe inhibition of the organisms. Obligate anaerobes rely on fermentation or anaerobic respiration. Examples include Clostridium perfringens and Fusobacterium spp.
  • Aerotolerant anaerobes: These bacteria can tolerate oxygen but do not use it for metabolism and growth. Examples include Streptococcus pyogenes and Cutibacterium acnes.

Anaerobic bacteria may be classified further as endogenous or exogenous anaerobes, depending on whether they are part of the normal human microbiota or found in the environment, respectively. Endogenous anaerobes constitute a significant portion of the normal human microbiota and outnumber aerobic bacteria at various mucosal sites, including the oral cavity and gastrointestinal tract. Additional sites of endogenous anaerobe colonization include the skin, upper respiratory tract, and genitourinary tract. In contrast, exogenous anaerobes are found in environmental sources, eg, soil, decaying organic matter, and water sediments.

Anaerobic infections typically occur when these organisms breach normally sterile body sites, often facilitated by trauma, surgical procedures, or disruption of mucosal barriers. Endogenous anaerobes are most frequently implicated, with infections developing at or near their normal sites of colonization. However, hematogenous dissemination may lead to infections at distant sites. Anaerobic bacteria have been isolated from infections involving virtually every organ or tissue in the body. Clinical presentations are variable, ranging from localized abscess formation to fulminant, life-threatening disease. 

Accurate diagnosis of anaerobic infections requires a high index of clinical suspicion, along with proper specimen collection and prompt transport under strict anaerobic conditions. Given their fastidious nature, anaerobes are challenging to isolate and may be missed if appropriate culture techniques are not employed. Timely recognition depends on both clinical awareness and consistent laboratory practices to ensure successful isolation and identification.

Etiology

Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care

Etiology

Anaerobic infections most commonly involve the oral cavity, abdominal region, and pelvic structures; however, they may also affect other areas, including the head, neck, and skin. Clinically significant anaerobes implicated in human infections include:

Gram-Positive Anaerobes

Gram-positive, spore-forming bacilli

Clostridium species are spore-forming bacilli that represent a significant subset of anaerobic pathogens associated with severe human infections.[2]

Clinically significant species include:

  • Clostridium perfringens: These organisms are commonly associated with gas gangrene (clostridial myonecrosis) and other soft tissue infections.
  • Clostridium septicum: These organisms are another cause of gas gangrene, often linked to underlying malignancy or immunosuppression.
  • Clostridium tetani: These organisms are the etiologic agent of tetanus, characterized by muscle rigidity and spasms due to tetanospasmin toxin.
  • Clostridium botulinum: This organism is responsible for botulism, a potentially fatal neuroparalytic illness caused by botulinum toxin.
  • Clostridioides difficile (formerly Clostridium difficile): This organism is the primary cause of antibiotic-associated diarrhea and pseudomembranous colitis.[3]

Gram-positive, nonspore-forming bacilli

Clinically significant species include:

  • Actinomyces: These organisms colonize the human gastrointestinal (GI) tract and oropharynx. Infections typically occur following disruption of mucocutaneous barriers. The most common anatomic sites of Actinomyces infection are cervicofacial, thoracic, and abdominal regions.
  • Bifidobacterium: Members of this genus are commensals of the human intestine and are generally considered non-pathogenic. However, rare infections have been reported, including chronic otitis media, abdominal abscesses, and peritonitis, particularly in immunocompromised individuals.
  • Cutibacterium (formerly Propionibacterium): These organisms are part of the normal flora of the skin and mucous membranes. The most clinically significant species is Cutibacterium acnes, which plays a role in the pathogenesis of acne vulgaris and is also implicated in prosthetic joint infections and other device-related infections.
  • Lactobacillus: Commonly found in the GI and genitourinary tracts, as well as in fermented foods, these organisms have low pathogenic potential. However, they have been associated with infections such as abdominal abscesses, aspiration pneumonia, and bacteremia, particularly in neonates and immunocompromised individuals.

Gram-Positive Cocci

Finegoldia magna and Parvimonas micra are anaerobic gram-positive cocci that were formerly classified under the genus Peptostreptococcus. They are part of the normal flora of the oral cavity, GI tract, upper respiratory tract, urogenital tract, and skin. Both species are opportunistic pathogens that have been implicated in infections, eg, chronic otitis media, sinusitis, aspiration pneumonia, pelvic inflammatory disease, particularly tubo-ovarian abscesses. Finegoldia magna is also associated with skin and soft tissue infections, prosthetic joint infections, and bacteremia.

Other clinically relevant anaerobic gram-positive organisms include Arcanobacterium, AtopobiumEggerthellaEubacterium, and the Streptococcus anginosus group (Streptococcus anginosus, Streptococcus constellatus, Streptococcus intermedius).

Gram-Negative Anaerobes

Gram-negative bacilli

Bacteroides are gram-negative bacilli that are the most commonly isolated anaerobic pathogens from clinical specimens. They are part of the normal flora of the human colon and female genital tract. Bacteroides fragilis is the most clinically significant species, known for its virulence and antimicrobial resistance. Members of this genus are frequently associated with intra-abdominal infections, particularly abscesses, which are often polymicrobial. Extra-abdominal infections caused by these organisms include bacteremia, aspiration pneumonia, and brain abscesses, among others.

Fusobacterium is part of the normal flora of the oral cavity and GI tract. They are important anaerobic pathogens, particularly in head and neck infections. Fusobacterium necrophorum is a significant pathogen in adolescents and young adults, where it can cause peritonsillar abscesses and pharyngitis. This can progress to a potentially life-threatening condition known as Lemierre syndrome, characterized by septic thrombophlebitis of the internal jugular vein, often accompanied by septic pulmonary emboli.[4]

Prevotella and Porphyromonas are organisms that are part of the normal flora of the oral cavity, GI tract, and genital tract. Prevotella species are commonly involved in head and neck infections, including peritonsillar and retropharyngeal abscesses, as well as perineal and perianal infections such as pilonidal abscesses. Porphyromonas species are primarily associated with periodontal disease and dental abscesses, but can also contribute to aspiration pneumonia and other head and neck infections.

Gram-Negative Cocci

Veillonella are gram-negative anaerobic cocci that are part of the normal flora of the oral cavity, GI tract, and female genital tract. They are occasionally implicated in clinical infections, including abdominal abscesses and aspiration pneumonia.[Mahon, CR, and Lehman, DC. Textbook of Diagnostic Microbiology. Seventh Edition. 2023.]

Epidemiology

Anaerobic bacteria are essential members of the human microbiota, predominantly colonizing the oral cavity, upper respiratory tract, gastrointestinal tract, and genitourinary tract, with colonization patterns influenced by anatomic site, age, diet, and environmental factors. These organisms play a vital role in maintaining mucosal homeostasis, aiding in digestion, and providing colonization resistance against opportunistic pathogens. While typically commensal, they can cause severe infections when mucosal integrity is compromised or in patients with immunosuppression. Examples of manifestations include brain and intra-abdominal abscesses, dental and periodontal infections, aspiration pneumonia, lung abscesses, bite wounds, necrotizing soft tissue infections, and anaerobic bacteremia.[5]

Pathophysiology

Anaerobic infections typically arise when mucosal or skin barriers are breached due to trauma, surgery, perforation, or tissue necrosis, allowing endogenous anaerobes to invade deeper tissues and thrive in the low-oxygen environment. Anaerobes deploy a variety of virulence factors, including adhesins, capsular polysaccharides, proteases, phospholipases, lipopolysaccharides, collagenases, and fibrinolysins, which facilitate adherence, evasion of phagocytosis, induction of inflammation, and abscess formation. These infections are usually polymicrobial, with multiple species interacting synergistically to enhance microbial growth and contribute to disease severity.

History and Physical

Clinical History

When evaluating a patient suspected of having an anaerobic infection, a detailed history is essential to identify risk factors and predisposing conditions, including:

  • Predisposing events: History of trauma, especially animal or human bites; recent surgery; or instrumentation in sites normally colonized by anaerobes (eg, oral cavity, gastrointestinal tract, female genital tract)
  • Obstructive or necrotic conditions: Inquire about symptoms or history of obstruction (eg, bowel obstruction, appendicitis) or tissue ischemia/necrosis that can facilitate anaerobic growth
  • Symptoms suggestive of abscess or deep infection: Localized pain, swelling, fluctuance, or foul-smelling discharge
  • Pulmonary risk factors: History of neurological impairment, dysphagia, or aspiration risk factors (eg, altered consciousness or impaired cough reflex)
  • Systemic symptoms: Fever, malaise, and signs of systemic toxicity may be present in severe or disseminated infections
  • Lack of response to antibiotics: Persistence or progression of symptoms despite antibiotic therapy targeting aerobic bacteria should raise suspicion for anaerobic involvement

Physical Examination

Characteristic findings on physical exam in the following areas include:

  • Local signs of infection
    • Tenderness, swelling, erythema, warmth, fluctuance, and induration in affected areas (eg, skin, soft tissue, or mucosal surfaces).
    • Foul-smelling or purulent discharge is characteristic of anaerobic infections and suggests necrotic tissue or abscess formation.
    • Necrosis or gangrene of the soft tissues may indicate an invasive anaerobic infection (eg, clostridial myonecrosis).
  • Head and neck
    • Dental infections present with localized facial swelling, tenderness, poor dentition, and sometimes trismus.
    • Peritonsillar or retropharyngeal abscesses manifest as throat pain, dysphagia, muffled voice, and neck stiffness. Examination may reveal tonsillar swelling, uvular deviation, or neck lymphadenopathy.
    • Lemierre syndrome may present with fever, neck pain, or swelling along the sternocleidomastoid muscle due to internal jugular vein thrombophlebitis.
  • Central nervous system (CNS)
    • Brain abscess symptoms include headache, focal neurological deficits, altered mental status, and signs of increased intracranial pressure.
    • An epidural abscess may present with localized back pain and neurological deficits.
  • Intra-abdominal
    • Abdominal pain, tenderness, guarding, and signs of peritonitis suggest anaerobic involvement secondary to bowel perforation or abscess formation.
    • Fever and signs of systemic infection may develop.
  • Pelvic inflammatory disease (PID)
    • Lower abdominal or pelvic pain, cervical motion tenderness, vaginal discharge, and fever.
    • Pelvic examination may reveal adnexal tenderness and cervical erythema.[6]
  • Pulmonary
    • Aspiration pneumonia or lung abscess may present with cough, purulent sputum (possibly foul-smelling), dyspnea, and chest pain.
    • Physical exam may reveal localized crackles or decreased breath sounds over abscessed areas.
  • Skin and soft tissue
    • Abscesses show localized swelling, fluctuance, and tenderness; perirectal abscesses may cause anal pain and swelling.
    • Necrotizing soft tissue infections may have rapidly progressing erythema, edema, pain disproportionate to the exam, and systemic toxicity.[7]

Evaluation

Evaluation of Severe Anaerobic Infections

Timely and accurate evaluation of suspected anaerobic infections is critical to guide early empiric therapy and prevent serious morbidity or mortality. These infections, often polymicrobial, include life-threatening conditions, eg, gas gangrene, tetanus, botulism, and Lemierre syndrome. Clinical suspicion should be guided by patient history, risk factors, and characteristic clinical features, with prompt specimen collection and appropriate laboratory and radiographic evaluation.

Clinical Suspicion and Initial Workup

The following key clinical triggers should heighten suspicion for certain anaerobic pathogens:

  • Gas gangrene (clostridial myonecrosis): Often associated with trauma, surgery, or ischemic tissue. Clinical signs include sudden severe pain, tissue crepitus, discoloration, and systemic toxicity. Clostridium perfringens or Clostridium septicum is a common culprit.
  • Tetanus: Consider in patients with a history of penetrating trauma, contaminated wounds, or necrotic tissue, especially if immunization status is unknown or incomplete. Early signs may include trismus (lockjaw), muscle rigidity, and spasms.
  • Botulism: Suspect in patients presenting with descending flaccid paralysis. In adults, this may follow ingestion of home-preserved foods; in infants, exposure to environmental spores (eg, through ingestion of honey). Adults may present with diplopia, ptosis, dysphagia, and progressive respiratory compromise.
  • Lemierre syndrome: Suspect in any adolescent or adult with recent oropharyngeal infection, worsening neck pain, fever, and signs of systemic sepsis. Fusobacterium necrophorum is the primary etiologic agent.

Specimen Collection and Handling

Accurate diagnosis of anaerobic infections relies heavily on proper specimen collection and transport, including:

  • Specimen source: Collect specimens directly from normally sterile sites, eg, blood, tissue, fluids, aspirates, or surgical specimens. Avoid surface swabs, which are often contaminated with commensal flora and provide limited diagnostic value.
  • Collection: Use needle aspiration or surgical biopsy when possible. Tissue, aspirates, and fluids are always preferred over swabs whenever possible. Place specimens in anaerobic transport media to preserve organism viability and minimize oxygen exposure.
  • Transport: Expedite transport to the laboratory at room temperature. Ideally, specimens should be processed for anaerobic culture within 2 hours. Maintain anaerobic conditions during transit.[8]

Laboratory Testing

Laboratory studies utilized in the evaluation of anaerobic infections include:

  • Anaerobic culture and identification: The use of selective and enriched anaerobic media enables optimal recovery and isolation of anaerobes. Pre-reduced blood agar plates supplemented with vitamin K1 and hemin are recommended. Advanced identification techniques, such as matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), provide rapid and highly accurate species-level identification. In addition, 16S rRNA gene sequencing can aid in identification when isolates are difficult to identify.
  • Toxin assays: In cases of suspected botulism, serum and stool samples should be sent for botulinum toxin testing. Contact public health authorities (eg, CDC or state health department) for consultation regarding testing and antitoxin release.
  • Blood cultures: Should be obtained before the initiation of antimicrobial therapy in any case of suspected systemic infection. Both aerobic and anaerobic bottles should be used to optimize recovery. Anaerobic bottles are essential for detecting organisms such as Bacteroides fragilis, Clostridium spp., and Fusobacterium spp.

Imaging Studies

The following radiographic evaluation supports the diagnosis and identifies complications:

  • Gas gangrene: Plain radiographs may show soft tissue gas but have limited sensitivity. Computed tomography (CT) imaging can more reliably detect gas and delineate muscular involvement. MRI offers superior soft-tissue contrast and is preferred for assessing the extent of necrosis and fascial-plane involvement.
  • Lemierre syndrome: Doppler ultrasound can identify internal jugular vein thrombosis, especially in early stages, but may be limited by patient anatomy or overlying edema. Contrast-enhanced CT of the neck is more sensitive and provides better visualization of deep neck structures. Chest CT or x-ray may reveal septic pulmonary emboli.
  • Abscesses: CT or magnetic resonance imaging (MRI) is indicated to localize deep-seated abscesses, particularly in the central nervous system (CNS), thoracic, abdominal, or pelvic regions. MRI is preferred for CNS or spinal epidural abscesses due to its superior soft-tissue resolution, whereas contrast-enhanced CT is often used for abdominal or pelvic abscesses.

Treatment / Management

Management of anaerobic infections requires a comprehensive approach that incorporates both surgical and medical interventions, tailored to the site of infection, patient comorbidities, and the presence of complications, eg, abscesses or necrosis.

Surgical and Interventional Management

The following procedural interventions are primarily used to treat anaerobic infections:

  • Abscess drainage is a cornerstone of treatment. Whenever feasible, abscesses should be drained, and specimens should be submitted for aerobic and anaerobic cultures to guide therapy.
  • Surgical debridement is essential in necrotizing infections (eg, clostridial myonecrosis, necrotizing fasciitis) to remove weakened tissue, limit systemic toxin effects, and improve antibiotic penetration.[9]
  • Percutaneous image-guided drainage may be appropriate for deep or anatomically challenging abscesses (eg, intra-abdominal, pelvic, or thoracic).[10]
  • (A1)

Empiric and Targeted Antimicrobial Therapy

Initiate empiric broad-spectrum antimicrobial therapy after appropriate cultures are obtained. Antibiotic regimens should include agents with reliable anaerobic coverage and be adjusted based on organism identification, susceptibility patterns, and clinical response. Frequently used agents include:

  • Metronidazole: Excellent activity against most gram-negative and gram-positive anaerobes (eg, Bacteroides fragilis, Clostridium spp.), except for some non-spore-forming gram-positive bacilli. High oral bioavailability and good tissue penetration, including the central nervous system and intra-abdominal sites. A common adverse effect is a metallic taste in the mouth, which can affect compliance.
  • Clindamycin: Moderate activity against gram-positive anaerobes but limited activity against gram-negative anaerobes. Less reliable than metronidazole, beta-lactam/beta-lactamase inhibitor combinations, or a carbapenem. Good tissue penetration, including bone and abscesses, but poor central nervous system penetration. 
  • Ampicillin, penicillin, and beta-lactam/beta-lactamase inhibitor combinations: Ampicillin and penicillin alone are active against many gram-positive anaerobes that do not produce beta-lactamases. However, most gram-negative anaerobes are resistant due to their production of beta-lactamases. Beta-lactam/beta-lactamase inhibitor combinations, eg, amoxicillin/clavulanate, ampicillin/sulbactam, and piperacillin/tazobactam, provide broad anaerobic coverage, including against beta-lactamase-producing anaerobes.
  • Carbapenems: Excellent anaerobic and broad-spectrum aerobic coverage. Preferred agents for resistant organisms or critical sites (eg, CNS, abdominal sepsis). Examples include meropenem, imipenem, and ertapenem.[CLSI. Performance Standards for Antimicrobial Susceptibility Testing, 35th Edition. 2025].

Differential Diagnosis

Neurologic manifestations of botulism may resemble Guillain-Barré syndrome, myasthenia gravis, brainstem stroke, or acute flaccid paralysis caused by enteroviruses or West Nile virus.[11] Anaerobic abscesses in the brain, lungs, head and neck, pelvis, or abdomen can resemble infections caused by aerobic or facultative bacteria, eg, Escherichia coli, Klebsiella spp., Pseudomonas aeruginosa, or Staphylococcus aureus. Fungal infections (eg, Aspergillus, Candida) and mycobacterial infections (eg, M tuberculosis in spinal or psoas abscesses) may also present similarly.

Malignancies, eg, colorectal or oropharyngeal cancers, can mimic anaerobic infections by producing space-occupying lesions or necrosis. Autoimmune and inflammatory conditions (eg, granulomatosis with polyangiitis or Crohn’s disease) can cause sterile abscesses or necrotic lesions resembling anaerobic infections.

Prognosis

The prognosis of anaerobic infections varies widely and depends on several factors, including the site of infection, timeliness of diagnosis, host comorbidities, and adequate source control. Favorable outcomes are common with early recognition and appropriate antimicrobial therapy, particularly in superficial or localized infections, eg, dental abscesses or uncomplicated aspiration pneumonia. However, delayed diagnosis or inadequate treatment can lead to serious complications, eg, necrotizing infections, brain abscesses, or intra-abdominal sepsis, often associated with high morbidity and mortality. Mixed infections involving facultative and anaerobic organisms may further complicate management and worsen outcomes. Patients with immunosuppression, malignancy, or diabetes are at increased risk of poor outcomes due to impaired host defenses and more aggressive infections. Ultimately, prognosis improves significantly with an interprofessional approach that includes timely microbiologic identification, susceptibility-guided therapy, and effective surgical or procedural source control.[12][13][14][15] 

Complications

Complications from anaerobic infections include rapid progression to necrotizing soft tissue disease (eg, gas gangrene, Fournier’s gangrene), pulmonary complications (eg, lung abscess or necrotizing pneumonia with risk of empyema or metastatic spread), and systemic sequelae, eg, septic shock, mycotic aneurysms, or secondary abscesses often seen with anaerobic bacteremia (notably Clostridium perfringens). Chronic wound infections harboring anaerobes commonly fail standard therapy, prolonging morbidity. Further, early broad-spectrum anaerobic coverage in critical care settings may paradoxically worsen outcomes due to disruption of the normal microbiota and pathogen overgrowth, highlighting the need for antimicrobial stewardship in high-risk patients. Surgical source control, appropriate selection of empirical therapy, and close clinical monitoring are imperative.[16][17]

Deterrence and Patient Education

Prevention of anaerobic infections relies on patient and family education regarding oral hygiene, aspiration avoidance, and proper wound care, especially in settings with neurological impairment or hypoxic tissue. Stewardship-focused education to avoid redundant anaerobic antibiotics is also critical, as overuse disrupts gut microbiota and may worsen outcomes. Spaced education significantly enhances clinicians' prescribing behavior, while greater patient engagement in infection-control practices is needed in inpatient settings.[18][19]

Pearls and Other Issues

Suspect anaerobic involvement in infections adjacent to sites colonized by normal anaerobic flora that present with foul odor or failed standard therapy. Avoid sampling pitfalls by sending tissue, fluids, or aspirates promptly in anaerobic transport media. Empirical coverage with metronidazole, a beta-lactam/beta-lactamase inhibitor, or a carbapenem is essential; avoid clindamycin monotherapy given resistance among gram-negative anaerobes. Prevention hinges on source control and judicious antibiotic use, with hyperbaric oxygen and imaging-guided management for gas-forming infections.

Enhancing Healthcare Team Outcomes

Anaerobic bacteria are organisms that proliferate in low-oxygen environments and commonly originate from normal human microbiota. Infection occurs when mucosal or skin barriers are disrupted by trauma, surgery, or ischemia, allowing pathogens to invade sterile tissues. These infections are often polymicrobial and involve virulence factors that promote tissue destruction, inflammation, and abscess formation. Clinical manifestations range from localized abscesses with foul-smelling discharge to severe conditions such as necrotizing soft tissue infections, gas gangrene, and systemic toxicity. Diagnosis requires a high index of suspicion, appropriate specimen collection under anaerobic conditions, and timely use of imaging and microbiologic techniques. Management includes prompt empiric antimicrobial therapy with anaerobic coverage, followed by targeted therapy, and surgical drainage or debridement for source control.

Interprofessional collaboration improves outcomes by ensuring timely diagnosis, appropriate treatment selection, and prevention of complications. Physicians and advanced practitioners lead diagnostic evaluation and management decisions, while primary care clinicians facilitate early recognition and referral. Surgeons or interventional radiologists are often needed for drainage or source control.[20] Nurses monitor clinical status, administer therapies, and reinforce patient education. Pharmacists optimize antimicrobial selection, dosing, and stewardship. Laboratory personnel ensure accurate specimen processing and organism identification. Interprofessional collaboration, guided by stewardship principles and clear communication among healthcare team members, improves patient safety, reduces unnecessary antibiotic use, and supports better outcomes for patients with anaerobic infections.[21]

References


[1]

Khademian M, Imlay JA. Do reactive oxygen species or does oxygen itself confer obligate anaerobiosis? The case of Bacteroides thetaiotaomicron. Molecular microbiology. 2020 Aug:114(2):333-347. doi: 10.1111/mmi.14516. Epub 2020 May 19     [PubMed PMID: 32301184]

Level 3 (low-level) evidence

[2]

Stabler S, Titécat M, Duployez C, Wallet F, Loïez C, Bortolotti P, Faure E, Faure K, Kipnis E, Dessein R, Le Guern R. Clinical relevance of Clostridium bacteremia: An 8-year retrospective study. Anaerobe. 2020 Jun:63():102202. doi: 10.1016/j.anaerobe.2020.102202. Epub 2020 Apr 1     [PubMed PMID: 32247000]

Level 2 (mid-level) evidence

[3]

Mada PK, Alam MU. Clostridioides difficile infection. StatPearls. 2026 Jan:():     [PubMed PMID: 28613708]


[4]

Tiwari A. Lemierre's Syndrome in the 21st Century: A Literature Review. Cureus. 2023 Aug:15(8):e43685. doi: 10.7759/cureus.43685. Epub 2023 Aug 18     [PubMed PMID: 37724228]


[5]

Cobo F. Antimicrobial Susceptibility and Clinical Findings of Anaerobic Bacteria. Antibiotics (Basel, Switzerland). 2022 Mar 7:11(3):. doi: 10.3390/antibiotics11030351. Epub 2022 Mar 7     [PubMed PMID: 35326814]


[6]

Taira T, Broussard N, Bugg C. Pelvic inflammatory disease: diagnosis and treatment in the emergency department. Emergency medicine practice. 2022 Dec:24(12):1-24     [PubMed PMID: 36378827]


[7]

Hua C, Urbina T, Bosc R, Parks T, Sriskandan S, de Prost N, Chosidow O. Necrotising soft-tissue infections. The Lancet. Infectious diseases. 2023 Mar:23(3):e81-e94. doi: 10.1016/S1473-3099(22)00583-7. Epub 2022 Oct 14     [PubMed PMID: 36252579]


[8]

Miller JM, Binnicker MJ, Campbell S, Carroll KC, Chapin KC, Gonzalez MD, Harrington A, Jerris RC, Kehl SC, Leal SM Jr, Patel R, Pritt BS, Richter SS, Robinson-Dunn B, Snyder JW, Telford S 3rd, Theel ES, Thomson RB Jr, Weinstein MP, Yao JD. Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2024 Mar 5:():. pii: ciae104. doi: 10.1093/cid/ciae104. Epub 2024 Mar 5     [PubMed PMID: 38442248]


[9]

Ge X, Sun Y, Lin J, Zhou F, Yao G, Luo B, Su X. Diagnostic Key Points and Surgical Management of Necrotizing Fasciitis: A Retrospective Study. The international journal of lower extremity wounds. 2024 Mar:23(1):153-160. doi: 10.1177/15347346211045282. Epub 2021 Oct 6     [PubMed PMID: 34612747]

Level 2 (mid-level) evidence

[10]

Limardo A, Blanco L, Menéndez J, Ortega A. Ultrasound-guided Drainage vs Surgical Drainage of Deep Neck Space Abscesses: A Randomized Controlled Trial. Acta otorrinolaringologica espanola. 2022 Jan-Feb:73(1):4-10. doi: 10.1016/j.otoeng.2020.08.008. Epub     [PubMed PMID: 35190087]

Level 1 (high-level) evidence

[11]

Rao AK, Sobel J, Chatham-Stephens K, Luquez C. Clinical Guidelines for Diagnosis and Treatment of Botulism, 2021. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports. 2021 May 7:70(2):1-30. doi: 10.15585/mmwr.rr7002a1. Epub 2021 May 7     [PubMed PMID: 33956777]


[12]

Mortensen KK, Nielsen HL, Søgaard KK. Clinical and microbiological characteristics of anaerobic bacteremia during 1994-2019: A Danish population-based cohort study. Anaerobe. 2024 Oct:89():102898. doi: 10.1016/j.anaerobe.2024.102898. Epub 2024 Aug 13     [PubMed PMID: 39147014]


[13]

Zouggari Y, Lelubre C, Lali SE, Cherifi S. Epidemiology and outcome of anaerobic bacteremia in a tertiary hospital. European journal of internal medicine. 2022 Nov:105():63-68. doi: 10.1016/j.ejim.2022.08.024. Epub 2022 Aug 31     [PubMed PMID: 36055955]


[14]

Piña Delgado C, Bolaños Rivero M, Carmona Tello MC, Ramírez Estupiñán CJ, Hernández Cabrera PM, de Miguel Martínez I. [Bacteremia due to strict anaerobes]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia. 2025 Feb:38(1):21-27. doi: 10.37201/req/063.2024. Epub 2024 Nov 18     [PubMed PMID: 39552499]


[15]

Kovács K, Nyul A, Lutz Z, Mestyán G, Gajdács M, Urbán E, Sonnevend Á. Incidence and Clinical Characteristics of Anaerobic Bacteremia at a University Hospital in Hungary: A 5-Year Retrospective Observational Study. Antibiotics (Basel, Switzerland). 2022 Sep 28:11(10):. doi: 10.3390/antibiotics11101326. Epub 2022 Sep 28     [PubMed PMID: 36289984]

Level 2 (mid-level) evidence

[16]

Coluccio A, Lopez Palomera F, Spero MA. Anaerobic bacteria in chronic wounds: Roles in disease, infection and treatment failure. Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society. 2024 Nov-Dec:32(6):840-857. doi: 10.1111/wrr.13208. Epub 2024 Aug 12     [PubMed PMID: 39129662]


[17]

Chanderraj R, Baker JM, Kay SG, Brown CA, Hinkle KJ, Fergle DJ, McDonald RA, Falkowski NR, Metcalf JD, Kaye KS, Woods RJ, Prescott HC, Sjoding MW, Dickson RP. In critically ill patients, anti-anaerobic antibiotics increase risk of adverse clinical outcomes. The European respiratory journal. 2023 Feb:61(2):. doi: 10.1183/13993003.00910-2022. Epub 2023 Feb 9     [PubMed PMID: 36229047]

Level 2 (mid-level) evidence

[18]

Kullberg RFJ, Haak BW, Chanderraj R, Prescott HC, Dickson RP, Wiersinga WJ. Empirical antibiotic therapy for sepsis: save the anaerobic microbiota. The Lancet. Respiratory medicine. 2025 Jan:13(1):92-100. doi: 10.1016/S2213-2600(24)00257-1. Epub 2024 Oct 11     [PubMed PMID: 39401510]


[19]

Flett KB, Bousvaros A, Carpenter J, Millrinen CE, Martin P, Sandora TJ. Reducing Redundant Anaerobic Therapy Through Spaced Education and Antimicrobial Stewardship Interventions. Journal of the Pediatric Infectious Diseases Society. 2018 Dec 3:7(4):317-322. doi: 10.1093/jpids/pix090. Epub     [PubMed PMID: 29165636]


[20]

Schmid S, Schlosser S, Gülow K, Pavel V, Müller M, Kratzer A. Interprofessional Collaboration between ICU Physicians, Staff Nurses, and Hospital Pharmacists Optimizes Antimicrobial Treatment and Improves Quality of Care and Economic Outcome. Antibiotics (Basel, Switzerland). 2022 Mar 13:11(3):. doi: 10.3390/antibiotics11030381. Epub 2022 Mar 13     [PubMed PMID: 35326844]

Level 2 (mid-level) evidence

[21]

Palavecino EL, Williamson JC, Ohl CA. Collaborative Antimicrobial Stewardship: Working with Microbiology. Infectious disease clinics of North America. 2020 Mar:34(1):51-65. doi: 10.1016/j.idc.2019.10.006. Epub 2019 Dec 10     [PubMed PMID: 31836331]